The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy
Open accessAbstract
Chronic viral infections are characterized by a state of CD8+ T-cell dysfunction that is associated with expression of the programmed cell death 1 (PD-1) inhibitory receptor. A better understanding of the mechanisms that regulate CD8+ T-cell responses during chronic infection is required to improve immunotherapies that restore function in exhausted CD8+ T cells. Here we identify a population of virus-specific CD8+ T cells that proliferate after blockade of the PD-1 inhibitory pathway in mice chronically infected with lymphocytic choriomeningitis virus (LCMV). These LCMV-specific CD8+ T cells expressed the PD-1 inhibitory receptor, but also expressed several costimulatory molecules such as ICOS and CD28. This CD8+ T-cell subset was characterized by a unique gene signature that was related to that of CD4+ T follicular helper (T FH) cells, CD8+ T cell memory precursors and haematopoietic stem cell progenitors, but that was distinct from that of CD4+ T H 1 cells and CD8+ terminal effectors. This CD8+ T-cell population was found only in lymphoid tissues and resided predominantly in the T-cell zones along with naive CD8+ T cells. These PD-1+CD8+ T cells resembled stem cells during chronic LCMV infection, undergoing self-renewal and also differentiating into the terminally exhausted CD8+ T cells that were present in both lymphoid and non-lymphoid tissues. The proliferative burst after PD-1 blockade came almost exclusively from this CD8+ T-cell subset. Notably, the transcription factor TCF1 had a cell-intrinsic and essential role in the generation of this CD8+ T-cell subset. These findings provide a better understanding of T-cell exhaustion and have implications in the optimization of PD-1-directed immunotherapy in chronic infections and cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Progenitor Tex (Tprog) cells retain stemness and self-renewal capacity that respond to immune checkpoint blockade (ICB) therapies and differentiate into intermediate T (Tint) cells with cytolytic capacity8–10.”
From Proteotoxic stress response drives T cell exhaustion and immune evasion (2025) · cites this paper as [10]
Experimental — accuracy not yet measuredIn the citing paper
“Two recent studies have shown that it is indeed CD28-expressing cells rather than already terminally differentiated effector cells that respond to PD-1 blockade with a proliferative burst and differentiation (94, 95).”
From Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, Efficacy, and Limitations (2018) · cites this paper as [94]
In the citing paper
“Preclinical models demonstrated that PD-1 blockade results in tumor rejection through reinvigoration of exhausted CD8 T cells that express PD-1, LAG3, and TIM3 and expansion of CD8 T cells, a hallmark of response to anti-PD-1 therapy (16).”
From The Next Decade of Immune Checkpoint Therapy (2021) · cites this paper as [16]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Takeda, K., Kaisho, T., & Akira, S. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141126 · Cited by 6,143
The future of immune checkpoint therapy
Sharma, P., & Allison, J. P. (2015) · Science · doi:10.1126/science.aaa8172 · Cited by 4,878
Restoring function in exhausted CD8 T cells during chronic viral infection
Barber, D. L., Wherry, E. J., Masopust, D., Zhu, B., Allison, J. P., Sharpe, A. H., Freeman, G. J., & Ahmed, R. (2005) · Nature · doi:10.1038/nature04444 · Cited by 4,057
Self-citationFollicular Helper CD4 T Cells (T FH )
Crotty, S. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101400 · Cited by 2,738
A role for Wnt signalling in self-renewal of haematopoietic stem cells
Reya, T., Duncan, A. W., Ailles, L., Domen, J., Scherer, D. C., Willert, K., Hintz, L., Nusse, R., & Weissman, I. L. (2003) · Nature · doi:10.1038/nature01593 · Cited by 2,159
Blackburn, S. D., Shin, H., Haining, W. N., Zou, T., Workman, C. J., Polley, A., Betts, M. R., Freeman, G. J., Vignali, D. A. A., & Wherry, E. J. (2009) · Nature Immunology · doi:10.1038/ni.1679 · Cited by 2,062
Self-citationViral Immune Evasion Due to Persistence of Activated T Cells Without Effector Function
Zajac, A. J., Blattman, J. N., Murali-Krishna, K., Sourdive, D. J. D., Suresh, M., Altman, J. D., & Ahmed, R. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2205 · Cited by 1,978
Self-citationCounting Antigen-Specific CD8 T Cells: A Reevaluation of Bystander Activation during Viral Infection
Murali‐Krishna, K., Altman, J. D., Suresh, M., Sourdive, D. J. D., Zajac, A. J., Miller, J. D., Slansky, J. E., & Ahmed, R. (1998) · Immunity · doi:10.1016/s1074-7613(00)80470-7 · Cited by 1,918
Self-citationJoshi, N. S., Cui, W., Chandele, A., Lee, H. K., Urso, D. R., Hagman, J., Gapin, L., & Kaech, S. M. (2007) · Immunity · doi:10.1016/j.immuni.2007.07.010 · Cited by 1,861
Monney, L., Sabatos, C. A., Gaglia, J. L., Ryu, A., Waldner, H., Chernova, T., Manning, S., Greenfield, E. A., Coyle, A. J., Sobel, R. A., et al. (2002) · Nature · doi:10.1038/415536a · Cited by 1,677
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–400 of 1,003
Rashidian, M., LaFleur, M. W., Verschoor, V. L., Dongre, A., Zhang, Y., Nguyen, T. H., Kolifrath, S. C., Aref, A. R., Lau, C. J., Paweletz, C. P., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1905005116 · Cited by 131
Self-citationHypophysitis induced by immune checkpoint inhibitors: a 10-year assessment
Dalmazi, G. D., Ippolito, S., Lupi, I., & Caturegli, P. (2019) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2019.1701434 · Cited by 134
Papavassiliou, A. G., & Musti, A. M. (2020) · Cells · doi:10.3390/cells9112470 · Cited by 124
Horton, B. L., Morgan, D. M., Momin, N., Zagorulya, M., Torres-Mejia, E., Bhandarkar, V., Wittrup, K. D., Love, J. C., & Spranger, S. (2021) · Science Immunology · doi:10.1126/sciimmunol.abi8800 · Cited by 124
Zappasodi, R., Budhu, S., Hellmann, M. D., Postow, M. A., Şenbabaoğlu, Y., Manne, S., Gasmi, B., Liu, C., Zhong, H., Li, Y., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.09.007 · Cited by 124
Mazzaschi, G., Facchinetti, F., Missale, G., Canetti, D., Madeddu, D., Zecca, A., Veneziani, M., Gelsomino, F., Goldoni, M., Buti, S., et al. (2018) · Lung Cancer · doi:10.1016/j.lungcan.2018.11.038 · Cited by 124
Kilian, M., Sheinin, R., Tan, C. L., Friedrich, M., Krämer, C., Kaminitz, A., Sanghvi, K., Lindner, K. A. M., Chih, Y., Cichon, F., et al. (2023) · Cancer Cell · doi:10.1016/j.ccell.2022.12.007 · Cited by 124
McLane, L. M., Ngiow, S. F., Chen, Z., Attanasio, J., Manne, S., Ruthel, G. T., Wu, J. E., Staupe, R. P., Xu, W., Amaravadi, R. K., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109120 · Cited by 127
High endothelial venules in cancer: Regulation, function, and therapeutic implication
Vella, G., Hua, Y., & Bergers, G. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.02.002 · Cited by 132
Dynamics of SIV-specific CXCR5+ CD8 T cells during chronic SIV infection
Mylvaganam, G., Ríos, D., Abdelaal, H. M., Iyer, S. S., Tharp, G. K., Mavigner, M., Hicks, S. L., Chahroudi, A., Ahmed, R., Bosinger, S. E., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1621418114 · Cited by 122
Self-citationSnell, L. M., MacLeod, B. L., Law, J. C., Osokine, I., Elsaesser, H. J., Hezaveh, K., Dickson, R. J., Gavin, M. A., Guidos, C. J., McGaha, T. L., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.08.002 · Cited by 122
Li, Y., Tang, L., Guo, L., Chen, C., Gu, S., Zhou, Y., Ye, G., Li, X., Wang, W., Liao, X., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.09.031 · Cited by 122
PD-1+ stemlike CD8 T cells are resident in lymphoid tissues during persistent LCMV infection
Im, S. J., Konieczny, B. T., Hudson, W. H., Masopust, D., & Ahmed, R. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1917298117 · Cited by 124
Self-citationImmune checkpoint inhibitors in advanced non–small cell lung cancer
Assi, H. I., Kamphorst, A. O., Moukalled, N. M., & Ramalingam, S. S. (2017) · Cancer · doi:10.1002/cncr.31105 · Cited by 123
Heterogeneity and fate choice: T cell exhaustion in cancer and chronic infections
Philip, M., & Schietinger, A. (2019) · Current Opinion in Immunology · doi:10.1016/j.coi.2019.04.014 · Cited by 128
A unified atlas of CD8 T cell dysfunctional states in cancer and infection
Pritykin, Y., van der Veeken, J., Pine, A. R., Zhong, Y., Şahin, M., Mažutis, L., Pe’er, D., Rudensky, A. Y., & Leslie, C. S. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.03.045 · Cited by 117
Giles, J. R., Manne, S., Freilich, E., Oldridge, D. A., Baxter, A. E., George, S. M., Chen, Z., Huang, H., Chilukuri, L., Carberry, M., et al. (2022) · Immunity · doi:10.1016/j.immuni.2022.02.004 · Cited by 121
Pichler, A., Carrié, N., Cuisinier, M., Ghazali, S., Voisin, A., Axisa, P., Tosolini, M., Mazzotti, C., Golec, D. P., Mahéo, S., et al. (2023) · Immunity · doi:10.1016/j.immuni.2023.06.007 · Cited by 124
Transcriptional regulatory network for the establishment of CD8+ T cell exhaustion
Seo, W., Jerin, C., & Nishikawa, H. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00568-0 · Cited by 125
Intratumoral follicular regulatory T cells curtail anti-PD-1 treatment efficacy
Eschweiler, S., Clarke, J. D., Ramírez-Suástegui, C., Panwar, B., Madrigal, A., Chee, S., Karydis, I., Woo, E. B. C., Alzetani, A., Elsheikh, S. E., et al. (2021) · Nature Immunology · doi:10.1038/s41590-021-00958-6 · Cited by 119
Oh, S. Y., Kim, S., Keam, B., Kim, T. M., Kim, D., & Heo, D. S. (2021) · Scientific Reports · doi:10.1038/s41598-021-99311-y · Cited by 127
A local human Vδ1 T cell population is associated with survival in nonsmall-cell lung cancer
Wu, Y., Biswas, D., Usaite, I., Angelova, M., Boeing, S., Karasaki, T., Veeriah, S., Czyzewska-Khan, J., Morton, C., Joseph, M., et al. (2022) · Nature Cancer · doi:10.1038/s43018-022-00376-z · Cited by 126
Single-cell analyses identify circulating anti-tumor CD8 T cells and markers for their enrichment
Pauken, K. E., Shahid, O., Lagattuta, K. A., Mahuron, K. M., Luber, J. M., Lowe, M. M., Huang, L., Delaney, C., Long, J. M., Fung, M. E., et al. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20200920 · Cited by 116
Self-citationImproving CAR T-Cell Persistence
Pietrobon, V., Todd, L. A., Goswami, A., Stefanson, O., Yang, Z., & Marincola, F. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910828 · Cited by 124
TCR-T Immunotherapy: The Challenges and Solutions
Liu, Y., Yan, X., Zhang, F., Zhang, X., Tang, F., Han, Z., & Li, Y. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2021.794183 · Cited by 117
Lim, R. J., Salehi‐Rad, R., Tran, L. M., Oh, M. S., Dumitras, C., Crosson, W. P., Li, R., Patel, T. S., Man, S., Yean, C. E., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101479 · Cited by 120
TCF1 expression marks self-renewing human CD8+ T cells
Kratchmarov, R., Magun, A. M., & Reiner, S. L. (2018) · Blood Advances · doi:10.1182/bloodadvances.2018016279 · Cited by 116
Peng, C., Huggins, M. A., Wanhainen, K. M., Knutson, T. P., Lu, H., Georgiev, H., Mittelsteadt, K. L., Jarjour, N. N., Wang, H., Hogquist, K. A., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.11.017 · Cited by 114
Dhodapkar, K. M., Cohen, A. D., Kaushal, A., Garfall, A. L., Manalo, R. J., Carr, A. R., McCachren, S. S., Stadtmauer, E. A., Lacey, S. F., Melenhorst, J. J., et al. (2022) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-22-0018 · Cited by 119
Human circulating and tissue-resident memory CD8+ T cells
Buggert, M., Price, D. A., Mackay, L. K., & Betts, M. R. (2023) · Nature Immunology · doi:10.1038/s41590-023-01538-6 · Cited by 125
Wang, K., Coutifaris, P., Brocks, D., Wang, G., Azar, T., Solis, S., Nandi, A., Anderson, S., Han, N. A., Manne, S., et al. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.08.007 · Cited by 127
Xu, F., Lin, H., He, P., He, L., Chen, J., Lin, L., & Chen, Y. (2020) · OncoImmunology · doi:10.1080/2162402x.2020.1731943 · Cited by 117
In vivo labeling reveals continuous trafficking of TCF-1+ T cells between tumor and lymphoid tissue
Li, Z., Tuong, Z. K., Dean, I., Willis, C., Gaspal, F., Fiancette, R., Idris, S., Kennedy, B. C., Ferdinand, J. R., Peñalver, A., et al. (2022) · The Journal of Experimental Medicine · doi:10.1084/jem.20210749 · Cited by 122
Dan, J. M., Havenar‐Daughton, C., Kendric, K. J., Al-Kolla, R., Kaushik, K., Rosales, S. L., Anderson, E. L., LaRock, C. N., Vijayanand, P., Seumois, G., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aau3776 · Cited by 114
Duckworth, B. C., Lafouresse, F., Wimmer, V. C., Broomfield, B. J., Dalit, L., Alexandre, Y. O., Sheikh, A. A., Qin, R. Z., Alvarado, C., Mielke, L. A., et al. (2021) · Nature Immunology · doi:10.1038/s41590-021-00878-5 · Cited by 113
Reuter, M. A., Estrada, P. M. D. R., Buggert, M., Petrovas, C., Ferrando‐Martínez, S., Nguyen, S., Japp, A. S., Ablanedo‐Terrazas, Y., Rivero-Arrieta, A., Kuri-Cervantes, L., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.11.075 · Cited by 109
Li, J., Wu, C. Y., Chen, M., Liu, S., Yan, S., Kang, Y., Sun, C., Grandis, J. R., Zeng, M., & Zhong, Q. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-002101 · Cited by 115
Dähling, S., Mansilla, A. M., Knöpper, K., Grafen, A., Utzschneider, D. T., Ugur, M., Whitney, P. G., Bachem, A., Arampatzi, P., Imdahl, F., et al. (2022) · Immunity · doi:10.1016/j.immuni.2022.03.006 · Cited by 109
Anabolism-Associated Mitochondrial Stasis Driving Lymphocyte Differentiation over Self-Renewal
Adams, W. C. T., Chen, Y., Kratchmarov, R., Yen, B., Nish, S. A., Lin, W.-H. W., Rothman, N. J., Luchsinger, L. L., Klein, U., Busslinger, M., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.11.065 · Cited by 113
Sudmeier, L. J., Hoang, K. B., Nduom, E. K.-E., Wieland, A., Neill, S. G., Schniederjan, M., Ramalingam, S. S., Olson, J. J., Ahmed, R., & Hudson, W. H. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100620 · Cited by 111
Self-citationQiu, J., Xu, B., Ye, D., Ren, D., Wang, S., Benci, J. L., Xu, Y., Ishwaran, H., Beltra, J., Wherry, E. J., et al. (2023) · Nature Cancer · doi:10.1038/s43018-022-00490-y · Cited by 117
Ngiow, S. F., Manne, S., Huang, Y., Azar, T., Chen, Z., Mathew, D., Chen, Q., Khan, O., Wu, J. E., Alcalde, V., et al. (2024) · Cell · doi:10.1016/j.cell.2024.07.018 · Cited by 116
Self-citationThe Single-Cell Phenotypic Identity of Human CD8+ and CD4+ T Cells
Brummelman, J., Pilipow, K., & Lugli, E. (2018) · International review of cytology · doi:10.1016/bs.ircmb.2018.05.007 · Cited by 113
Wisdom, A. J., Mowery, Y. M., Hong, C. S., Himes, J. E., Nabet, B. Y., Qin, X., Zhang, D., Chen, L., Fradin, H., Patel, R., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19917-0 · Cited by 113
Insights From Antiviral Therapy Into Immune Responses to Hepatitis B and C Virus Infection
Rehermann, B., & Thimme, R. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.08.061 · Cited by 109
Characterization of Human CD8 T Cell Responses in Dengue Virus-Infected Patients from India
Chandele, A., Sewatanon, J., Gunisetty, S., Singla, M., Onlamoon, N., Akondy, R. S., Kissick, H. T., Nayak, K., Reddy, E. S., Kalam, H., et al. (2016) · Journal of Virology · doi:10.1128/jvi.01424-16 · Cited by 104
Self-citationCancer cell-intrinsic mechanisms driving acquired immune tolerance
Ghorani, E., Swanton, C., & Quezada, S. A. (2023) · Immunity · doi:10.1016/j.immuni.2023.09.004 · Cited by 116
Regulation of CD8+ T cells by lipid metabolism in cancer progression
Tang, Y., Chen, Z., Zuo, Q., & Kang, Y. (2024) · Cellular and Molecular Immunology · doi:10.1038/s41423-024-01224-z · Cited by 124
Nutrient-driven histone code determines exhausted CD8 + T cell fates
Ma, S., Dahabieh, M. S., Mann, T. H., Zhao, S., McDonald, B., Song, W., Chung, H., Farsakoglu, Y., Garcia-Rivera, L., Hoffmann, F. A., et al. (2024) · Science · doi:10.1126/science.adj3020 · Cited by 118
Stem, Effector, and Hybrid States of Memory CD8+ T Cells
Lugli, E., Galletti, G., Boi, S. K., & Youngblood, B. (2019) · Trends in Immunology · doi:10.1016/j.it.2019.11.004 · Cited by 107
Role of the Orphan Nuclear Receptor NR4A Family in T-Cell Biology
Odagiu, L., May, J., Boulet, S., Baldwin, T. A., & Labrecque, N. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.624122 · Cited by 110
Wang, R., Kim, K.-H., Yoo, J., Li, X., Kwon, N., Jeon, Y., Shin, S.-K., Han, S. S., Lee, D., & Yoon, J. (2022) · ACS Nano · doi:10.1021/acsnano.1c10565 · Cited by 106
CD4+ T cell effector commitment coupled to self-renewal by asymmetric cell divisions
Nish, S. A., Zens, K. D., Kratchmarov, R., Lin, W.-H. W., Adams, W. C. T., Chen, Y.-H., Yen, B., Rothman, N. J., Bhandoola, A., Xue, H., et al. (2016) · The Journal of Experimental Medicine · doi:10.1084/jem.20161046 · Cited by 100
Self-citationZhang, N., Song, J., Liu, Y., Liu, M., Zhang, L., Sheng, D., Deng, L., Yi, H., Wu, M., Zheng, Y., et al. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.05.036 · Cited by 104
Weisberg, S. P., Carpenter, D. J., Chait, M., Dogra, P., Gartrell, R. D., Chen, A., Campbell, S., Liu, W., Saraf, P., Snyder, M. E., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.11.056 · Cited by 104
Immunotherapy Goes Local: The Central Role of Lymph Nodes in Driving Tumor Infiltration and Efficacy
van Pul, K. M., Fransen, M. F., van de Ven, R., & de Gruijl, T. D. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.643291 · Cited by 105
LSD1 inhibition sustains T cell invigoration with a durable response to PD-1 blockade
Liu, Y., Debo, B. M., Li, M., Shi, Z., Sheng, W., & Shi, Y. (2021) · Nature Communications · doi:10.1038/s41467-021-27179-7 · Cited by 109
Okoye, I., Houghton, M., Tyrrell, D. L., Barakat, K., & Elahi, S. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01215 · Cited by 105
The Identity of Human Tissue-Emigrant CD8+ T Cells
Buggert, M., Vella, L. A., Nguyen, S., Wu, V. H., Chen, Z., Sekine, T., Perez‐Potti, A., Maldini, C. R., Manne, S., Darko, S. W., et al. (2020) · Cell · doi:10.1016/j.cell.2020.11.019 · Cited by 105
Memory T-Cell Heterogeneity and TerminologyPreprint
Muroyama, Y., & Wherry, E. J. (2021) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a037929 · Cited by 104
Francis, D. M., & Thomas, S. N. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.04.011 · Cited by 100
CD8+ T-Cell Response to HIV Infection in the Era of Antiretroviral Therapy
Perdomo-Celis, F., Taborda, N. A., & Rugeles, M. T. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01896 · Cited by 103
Control of Lymphocyte Fate, Infection, and Tumor Immunity by TCF-1
Raghu, D., Xue, H., & Mielke, L. A. (2019) · Trends in Immunology · doi:10.1016/j.it.2019.10.006 · Cited by 98
Self-citationCXCL13-CXCR5 axis: Regulation in inflammatory diseases and cancer
Wang, B., Wang, M., Ao, D., & Wei, X. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188799 · Cited by 110
Novel strategies for cancer immunotherapy: counter-immunoediting therapy
Liu, S., Sun, Q., & Ren, X. (2023) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01430-8 · Cited by 107
Role of CD4+ T Cells in the Control of Viral Infections: Recent Advances and Open Questions
Kervevan, J., & Chakrabarti, L. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020523 · Cited by 108
Chung, H. K., McDonald, B., & Kaech, S. M. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20201730 · Cited by 105
New developments implicating IL-21 in autoimmune disease
Ren, H. M., Lukacher, A. E., Rahman, Z. S. M., & Olsen, N. J. (2021) · Journal of Autoimmunity · doi:10.1016/j.jaut.2021.102689 · Cited by 100
Cellular and molecular mechanisms of CD8(+) T cell differentiation, dysfunction and exhaustion
Verdon, D. J., Mulazzani, M., & Jenkins, M. R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197357 · Cited by 98
Ozga, A. J., Chow, M. T., Lopes, M. E., Servis, R. L., Pilato, M. D., Dehio, P., Lian, J., Mempel, T. R., & Luster, A. D. (2021) · Immunity · doi:10.1016/j.immuni.2021.11.002 · Cited by 96
Long-Term Persistence of Exhausted CD8 T Cells in Chronic Infection Is Regulated by MicroRNA-155
Stelekati, E., Chen, Z., Manne, S., Kurachi, M., Ali, M.-A., Lewy, K., Cai, Z., Nzingha, K., McLane, L. M., Hope, J. L., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.04.038 · Cited by 98
Xu, Y., Carrascosa, L. C., Yeung, Y. A., Chu, M. L.-H., Yang, W., Djuretic, I. M., Pappas, D. C., Zeytounian, J. L., Ge, Z., de Ruiter, V., et al. (2021) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-21-0058 · Cited by 97
Extremely Differentiated T Cell Subsets Contribute to Tissue Deterioration During Aging
Soto‐Heredero, G., Heras, M. M. G. D. L., Escrig-Larena, J. I., & Mittelbrunn, M. (2023) · Annual Review of Immunology · doi:10.1146/annurev-immunol-101721-064501 · Cited by 96
The T cell differentiation landscape is shaped by tumour mutations in lung cancer
Ghorani, E., Reading, J. L., Henry, J. Y., de Massy, M. R., Rosenthal, R., Turati, V. A., Joshi, K., Furness, A. J. S., Aïssa, A. B., Saini, S. K., et al. (2020) · Nature Cancer · doi:10.1038/s43018-020-0066-y · Cited by 95
TCF-1: a maverick in T cell development and function
Gounari, F., & Khazaie, K. (2022) · Nature Immunology · doi:10.1038/s41590-022-01194-2 · Cited by 95
Rutella, S., Vadakekolathu, J. N., Mazziotta, F., Reeder, S., Yau, T. O., Mukhopadhyay, R., Dickins, B., Altmann, H., Krämer, M., Knaus, H. A., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci159579 · Cited by 96
Ando, S., Perkins, C. M., Sajiki, Y., Chastain, C., Valanparambil, R. M., Wieland, A., Hudson, W. H., Hashimoto, M., Ramalingam, S. S., Freeman, G. J., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci160025 · Cited by 96
Self-citationRegulation of CD8+ T memory and exhaustion by the mTOR signals
Chen, Y., Xu, Z., Sun, H., Ouyang, X., Han, Y., Yu, H., Wu, N., Xie, Y., & Su, B. (2023) · Cellular and Molecular Immunology · doi:10.1038/s41423-023-01064-3 · Cited by 101
In vitro modeling of CD8 + T cell exhaustion enables CRISPR screening to reveal a role for BHLHE40
Wu, J. E., Manne, S., Ngiow, S. F., Baxter, A. E., Huang, H., Freilich, E., Clark, M. L., Lee, J. H., Chen, Z., Khan, O., et al. (2023) · Science Immunology · doi:10.1126/sciimmunol.ade3369 · Cited by 101
Self-citationEpigenetic regulators of clonal hematopoiesis control CD8 T cell stemness during immunotherapy
Kang, T. G., Lan, X., Tian, M., Chen, H., Alli, S., Lim, S.-E., Bhatara, S., Vasandan, A. B., Ward, G., Bentivegna, S., et al. (2024) · Science · doi:10.1126/science.adl4492 · Cited by 103
Insights Into the Molecular Mechanisms of T Follicular Helper-Mediated Immunity and Pathology
Qin, L., Waseem, T. C., Sahoo, A., Bieerkehazhi, S., Zhou, H. Y., Galkina, E., & Nurieva, R. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01884 · Cited by 100
Role of TCF‐1 in differentiation, exhaustion, and memory of CD8 + T cells: A review
Zhang, J., Lyu, T., Cao, Y., & Feng, H. (2021) · The FASEB Journal · doi:10.1096/fj.202002566r · Cited by 109
Palmitoylation of TIM-3 promotes immune exhaustion and restrains antitumor immunity
Zhang, Z., Ren, C., Xiao, R., Ma, S., Liu, H., Dou, Y., Fan, Y., Wang, S., Zhan, P., Gao, C., et al. (2024) · Science Immunology · doi:10.1126/sciimmunol.adp7302 · Cited by 94
Utzschneider, D. T., Delpoux, A., Wieland, D., Huang, X., Lai, C.-Y., Hofmann, M., Thimme, R., & Hedrick, S. Μ. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.03.020 · Cited by 98
Precursors of exhausted T cells are pre-emptively formed in acute infection
Chu, T., Wu, M., Höllbacher, B., de Almeida, G. P., Wurmser, C., Berner, J., Donhauser, L. V., Gerullis, A.-K., Lin, S., Cepeda-Mayorga, J. D., et al. (2025) · Nature · doi:10.1038/s41586-024-08451-4 · Cited by 101
Efficient CRISPR/Cas9 Gene Editing in Uncultured Naive Mouse T Cells for In Vivo Studies
Nüssing, S., House, I. G., Kearney, C. J., Chen, A. X. Y., Vervoort, S. J., Beavis, P. A., Oliaro, J., Johnstone, R. W., Trapani, J. A., & Parish, I. A. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1901396 · Cited by 92
Shan, Q., Hu, S. S., Chen, X., Danahy, D. B., Badovinac, V. P., Zang, C., & Xue, H. (2020) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-0436-5 · Cited by 95
Self-citationSystemic CD4 Immunity as a Key Contributor to PD-L1/PD-1 Blockade Immunotherapy Efficacy
Zuazo, M., Arasanz, H., Bocanegra, A., Fernández, G., Chocarro, L., Vera, R., Kochan, G. T., & Escors, D. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.586907 · Cited by 97
BCL6 promotes a stem-like CD8 + T cell program in cancer via antagonizing BLIMP1
Sun, Q., Cai, D., Liu, D., Zhao, X., Li, R., Xu, W. M., Xie, B., Gou, M., Wei, K., Li, Y., et al. (2023) · Science Immunology · doi:10.1126/sciimmunol.adh1306 · Cited by 94
Imaging of anticancer drug action in single cells
Miller, M. A., & Weissleder, R. (2017) · Nature reviews. Cancer · doi:10.1038/nrc.2017.41 · Cited by 92
The role of the tumour microenvironment in immunotherapy
Gasser, S., Lim, L. H. K., & Cheung, F. S. G. (2017) · Endocrine Related Cancer · doi:10.1530/erc-17-0146 · Cited by 90
Wang, Y., Hu, J., Li, Y., Xiao, M., Wang, H., Qin, T., Li, Z., Tang, J., Li, H., Tan, Y. Q., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00169 · Cited by 92
Mazet, J. M., Mahale, J. N., Tong, O., Watson, R. A., Lechuga‐Vieco, A. V., Pirgova, G., Lau, V. W. C., Attar, M., Koneva, L. A., Sansom, S. N., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-35948-9 · Cited by 99
Combination anti–PD-1 and antiretroviral therapy provides therapeutic benefit against SIV
Mylvaganam, G., Chea, L. S., Tharp, G. K., Hicks, S. L., Velu, V., Iyer, S. S., Deléage, C., Estes, J. D., Bosinger, S. E., Freeman, G. J., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.122940 · Cited by 89
Self-citationZamora, A. E., Crawford, J. C., Allen, E. K., Guo, X.-Z. J., Bakke, J., Carter, R. A., Abdelsamed, H. A., Moustaki, A., Li, Y., Chang, T., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aat8549 · Cited by 93
CXCR5+PD-1+ follicular helper CD8 T cells control B cell tolerance
Chen, Y., Yu, M., Zheng, Y., Fu, G., Xin, G., Zhu, W., Luo, L., Burns, R., Li, Q., Dent, A. L., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12446-5 · Cited by 92
Xia, Y., Sándor, K., Pai, J. A., Dániel, B., Raju, S., Wu, R., Hsiung, S., Qi, Y., Tenzin, Y., Okamoto, M., et al. (2022) · Immunity · doi:10.1016/j.immuni.2022.05.003 · Cited by 91
Yin, J., Yuan, J., Li, Y., Fang, Y., Wang, R., Jiao, H., Tang, H., Zhang, S., Lin, S., Feng, S., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02469-3 · Cited by 97
Reprogramming T cell differentiation and exhaustion in CAR-T cell therapy
Bulliard, Y., Andersson, B. S., Baysal, M. A., Damiano, J. S., & Tsimberidou, A. M. (2023) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01504-7 · Cited by 98
Zhang, X., & Niedermann, G. (2018) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2018.01.094 · Cited by 94
Metadata
- Authors
- Im, S. J., Hashimoto, M., Gerner, M. Y., Lee, J., Kissick, H. T., Burger, M. C., Shan, Q., Hale, J. S., Lee, J., Nasti, T. H., Sharpe, A. H., Freeman, G. J., Germain, R. N., Nakaya, H. I., Xue, H.-H., & Ahmed, R.
- Affiliations
- Emory University (US)
- National Institutes of Health (US)
- University of Iowa (US)
- Brigham and Women's Hospital (US)
- Harvard University (US)
- Universidade de São Paulo (BR)
- Corresponding author
- Ahmed, Rafi
- ORCID
- Venue
- Nature
- Published
- 2016-08-02
- Volume
- 537
- Issue
- 7620
- Pages
- 417-421
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC5297183
- OpenAlex
- W2506616866
- Cited by
- 2,070
- References
- 37
- Citations by year
- 2026: 224 · 2025: 245 · 2024: 268 · 2023: 264 · 2022: 248 · 2021: 252 · 2020: 223 · 2019: 154 · 2018: 101 · 2017: 75 · 2016: 13
- FWCI
- 69.19
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institutes of Health (n01ai30048-10-0-1)
- National Institute of Allergy and Infectious Diseases (N01 AI030048, P01AI080192, P01AI056299, R01AI030048, R01AI121080, R01AI112579)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Keywords
- CD8+ T cells, PD-1, T cell exhaustion, lymphocytic choriomeningitis virus, chronic viral infection, B cell follicles, T follicular helper cells, PD-L1 blockade, anti-PD-1 therapy, HIV, virus control, costimulatory molecules
- MeSH terms
- Cell Self Renewal, Animals, Cell Differentiation, Female, T-Lymphocytes, Helper-Inducer, Hematopoietic Stem Cells, Immunotherapy, Lymphocytic Choriomeningitis, Lymphocytic choriomeningitis virus, T-Lymphocyte Subsets, CD28 Antigens, CD8-Positive T-Lymphocytes, Cell Proliferation, Mice, Hepatocyte Nuclear Factor 1-alpha, Inducible T-Cell Co-Stimulator Protein, Programmed Cell Death 1 Receptor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
